Sandra P. D’Angelo

2005–2025 年に発表

別表記: Sandra P. D'Angelo

97: 論文数
21,266: 被引用数
50: h 指数
89: i10 指数

被引用数

引用元

国・地域

0%27%その他 19.7%

機関

分野

トピック

全論文

並び替え

検索で開く

Tumor mutational load predicts survival after immunotherapy across multiple cancer types
著者: Robert Samstein, Chung‐Han Lee, Alexander N. Shoushtari, Matthew D. Hellmann, Ronglai Shen, Yelena Y. Janjigian, David Barron, Ahmet Zehir, Emmet Jordan, Antonio Omuro, Thomas Kaley, Sviatoslav M. Kendall, Robert J. Motzer, A. Ari Hakimi, Martin H. Voss, Paul Russo, Jonathan E. Rosenberg, Gopa Iyer, Bernard H. Bochner, Dean F. Bajorin, Hikmat Al‐Ahmadie, Jamie E. Chaft, Charles M. Rudin, Gregory J. Riely, Shrujal S. Baxi, Alan L. Ho, Richard J. Wong, David G. Pfister, Jedd D. Wolchok, Christopher A. Barker, Philip H. Gutin, Cameron Brennan, Viviane Tabar, Ingo K. Mellinghoff, Lisa M. DeAngelis, Charlotte E. Ariyan, Nancy Y. Lee, William D. Tap, Mrinal M. Gounder, Sandra P. D’Angelo, Leonard B. Saltz, Zsofia K. Stadler, Howard I. Scher, José Baselga, Pedram Razavi, Christopher A. Klebanoff, Rona Yaeger, Neil H. Segal, Geoffrey Y. Ku, Ronald P. DeMatteo, Marc Ladanyi, Naiyer A. Rizvi, Michael F. Berger, Nadeem Riaz, David B. Solit, Timothy A. Chan, Luc G.T. Morris - Nature Genetics 2019 被引用: 4,358
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
著者: Hussein A. Tawbi, Melissa Burgess, Vanessa Bolejack, Brian A. Van Tine, Scott M. Schuetze, James Hu, Sandra P. D’Angelo, Steven Attia, Richard F. Riedel, Dennis A. Priebat, Sujana Movva, Lara E. Davis, Scott H. Okuno, Damon R. Reed, John Crowley, Lisa H. Butterfield, Ruth Salazar, Jaime Rodriguez‐Canales, Alexander J. Lazar, Ignacio I. Wistuba, Laurence H. Baker, Robert G. Maki, Denise K. Reinke, Shreyaskumar Patel - The Lancet Oncology 2017 被引用: 1,423
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
著者: Jeffrey S. Weber, Sandra P. D’Angelo, David R. Minor, F. Stephen Hodi, Ralf Gutzmer, Bart Neyns, Christoph Höeller, Nikhil I. Khushalani, Wilson H. Miller, Christopher D. Lao, Gerald P. Linette, L. Thomas, Paul Lorigan, Kenneth F. Grossmann, Jessica C. Hassel, Michele Maio, Mario Sznol, Paolo A. Ascierto, Peter Mohr, Bartosz Chmielowski, Alan H. Bryce, Inge Marie Svane, Jean‐Jacques Grob, Angela M. Krackhardt, Christine E. Horak, Alexandre Lambert, Arvin Yang, James Larkin - The Lancet Oncology 2015 被引用: 2,666
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial
著者: Sandra P. D’Angelo, Dejka M. Araujo, Albiruni R. Abdul Razak, Mark Agulnik, Steven Attia, Jean‐Yves Blay, Irene Carrasco García, John A. Charlson, Edwin Choy, George D. Demetri, Mihaela Druta, Édouard Forcade, Kristen N. Ganjoo, John Glod, Vicki L. Keedy, Axel Le Cesne, David A. Liebner, Víctor Moreno, Seth M. Pollack, Scott M. Schuetze, Gary K. Schwartz, Sandra J. Strauss, William D. Tap, Fiona Thistlethwaite, Claudia Maria Valverde Morales, Michael J. Wagner, Breelyn A. Wilky, Cheryl McAlpine, Laura Hudson, Jean‐Marc Navenot, Tianjiao Wang, Jane P. F. Bai, Stavros Rafail, Ruoxi Wang, Amy Sun, Lilliam Fernandes, Erin Van Winkle, Erica Elefant, Colin Lunt, Elliot Norry, Dennis Williams, Swethajit Biswas, Brian Andrew Van Tine - The Lancet 2024 被引用: 263
Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials
著者: Sandra P. D’Angelo, Michelle R. Mahoney, Brian Andrew Van Tine, James N. Atkins, Mohammed Milhem, Balkrishna Jahagirdar, Cristina R. Antonescu, Elise Horvath, William D. Tap, Gary K. Schwartz, Howard Streicher - The Lancet Oncology 2018 被引用: 748
Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center
著者: Troy Z. Horvat, Nelly G. Adel, Thu-Oanh Dang, Parisa Momtaz, Michael A. Postow, Margaret K. Callahan, Richard D. Carvajal, Mark A. Dickson, Sandra P. D’Angelo, Kaitlin M. Woo, Katherine S. Panageas, Jedd D. Wolchok, Paul B. Chapman - Journal of Clinical Oncology 2015 被引用: 1,073
Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets
著者: Benjamin A. Nacev, Francisco Sánchez-Vega, Shaleigh Smith, Cristina R. Antonescu, Evan Rosenbaum, Hongyu Shi, Cerise Tang, Nicholas D. Socci, Satshil Rana, Rodrigo Gularte‐Mérida, Ahmet Zehir, Mrinal M. Gounder, Timothy G. Bowler, Anisha Luthra, Bhumika Jadeja, Azusa Okada, Jonathan A. Strong, Jake Stoller, Jason E. Chan, Ping Chi, Sandra P. D’Angelo, Mark A. Dickson, Ciara M. Kelly, Mary Louise Keohan, Sujana Movva, Katherine A. Thornton, Paul A. Meyers, Leonard H. Wexler, Emily K. Slotkin, Julia Glade Bender, Neerav Shukla, Martee L. Hensley, John H. Healey, Michael P. LaQuaglia, Kaled M. Alektiar, Aimeé M. Crago, Sam S. Yoon, Brian R. Untch, Sarah Chiang, Narasimhan P. Agaram, Meera Hameed, Michael F. Berger, David B. Solit, Nikolaus Schultz, Marc Ladanyi, Samuel Singer, William D. Tap - Nature Communications 2022 被引用: 211
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
著者: Howard L. Kaufman, Jeffery S. Russell, Omid Hamid, Shailender Bhatia, Patrick Terheyden, Sandra P. D’Angelo, Kent C. Shih, Célèste Lebbé, Gerald P. Linette, Michèle Milella, Isaac Brownell, Karl D. Lewis, Jochen H. Lorch, Kevin M. Chin, Lisa Mahnke, Anja von Heydebreck, Jean-Marie Cuillerot, Paul Nghiem - The Lancet Oncology 2016 被引用: 1,215
Phase I study of emactuzumab single agent or in combination with paclitaxel in patients with advanced/metastatic solid tumors reveals depletion of immunosuppressive M2-like macrophages
著者: C. Gomez-Roca, Antoîne Italiano, Christophe Le Tourneau, Philippe A. Cassier, Maud Toulmonde, Sandra P. D’Angelo, Mario Campone, Kristy Weber, Delphine Loirat, Michael A. Cannarile, Anna Maria Jegg, Carola H. Ries, R D Christen, Georgina Meneses‐Lorente, Wolfgang Jacob, Irina Klaman, Chia-Huey Ooi, Carl Watson, Kathrin Wonde, Bernhard Reis, Francesca Michielin, Dominik Rüttinger, Jean‐Pierre Delord, Jean‐Yves Blay - Annals of Oncology 2019 被引用: 202
Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS -Mutant Cancers
著者: Snjezana Doğan, Ronglai Shen, Daphne Ang, Melissa L. Johnson, Sandra P. D’Angelo, Paul K. Paik, Edyta B. Brzostowski, Gregory J. Riely, Mark G. Kris, Maureen F. Zakowski, Marc Ladanyi - Clinical Cancer Research 2012 被引用: 619
Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis
著者: Sandra P. D’Angelo, James Larkin, Jeffrey A. Sosman, Célèste Lebbé, Benjamin Brady, Bart Neyns, Henrik Schmidt, Jessica C. Hassel, F. Stephen Hodi, Paul Lorigan, Kerry J. Savage, Wilson H. Miller, Peter Mohr, Iván Márquez‐Rodas, J. Charles, Martin Kaatz, Mario Sznol, Jeffrey S. Weber, Alexander N. Shoushtari, Mary Ruisi, Joel Jiang, Jedd D. Wolchok - Journal of Clinical Oncology 2017 被引用: 643
Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259T Cells in Synovial Sarcoma
著者: Sandra P. D’Angelo, Luca Melchiori, Melinda S. Merchant, Donna Bernstein, John Glod, Rosandra N. Kaplan, Stephan A. Grupp, William D. Tap, Karen Chagin, Gwendolyn K. Binder, Samik Basu, Daniel E. Lowther, Ruoxi Wang, Natalie Bath, Alex J. Tipping, Gareth Betts, Indu Ramachandran, Jean‐Marc Navenot, Hua Zhang, Daniel K. Wells, Erin Van Winkle, Gabor Kari, Trupti Trivedi, Tom Holdich, Lini Pandite, Rafael G. Amado, Crystal L. Mackall - Cancer Discovery 2018 被引用: 435
Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator’s Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial
著者: James Larkin, David R. Minor, Sandra P. D’Angelo, Bart Neyns, Michael Smylie, Wilson H. Miller, Ralf Gutzmer, Gerald P. Linette, Bartosz Chmielowski, Christopher D. Lao, Paul Lorigan, Kenneth F. Grossmann, Jessica C. Hassel, Mario Sznol, Adil Daud, Jeffrey A. Sosman, Nikhil I. Khushalani, Dirk Schadendorf, Christoph Höeller, Dana Walker, George Kong, Christine E. Horak, Jeffrey S. Weber - Journal of Clinical Oncology 2017 被引用: 510
Anti-TIGIT Antibody Tiragolumab Alone or With Atezolizumab in Patients With Advanced Solid Tumors
著者: Tae Won Kim, Philippe L. Bédard, Patricia LoRusso, Michael S. Gordon, Johanna C. Bendell, Do‐Youn Oh, Myung‐Ju Ahn, Elena Garralda, Sandra P. D’Angelo, Jayesh Desai, F. Stephen Hodi, Zev A. Wainberg, Jean‐Pierre Delord, Phillippe A. Cassier, Andrés Cervantes, Marta Gil-Martín, Benjamin Wu, Namrata S. Patil, Yanling Jin, Tien Hoang, Diana Mendus, Xiaohui Wen, Raymond D. Meng, Byoung Chul Cho - JAMA Oncology 2023 被引用: 63
Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab
著者: Ciara M. Kelly, Cristina R. Antonescu, Timothy G. Bowler, Rodrigo Ramella Munhoz, Ping Chi, Mark A. Dickson, Mrinal M. Gounder, Mary Louise Keohan, Sujana Movva, Reena Dholakia, Hamza Ahmad, Matthew D. Biniakewitz, Mercedes M. Condy, Haley T. Phelan, Margaret K. Callahan, Phillip Wong, S. J. Singer, Charlotte E. Ariyan, Edmund K. Bartlett, Aimeé M. Crago, Sam S. Yoon, Sinchun Hwang, Joseph P. Erinjeri, Li‐Xuan Qin, William D. Tap, Sandra P. D’Angelo - JAMA Oncology 2020 被引用: 205
First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study
著者: Sandra P. D’Angelo, Célèste Lebbé, Laurent Mortier, Andrew S. Brohl, Nicola Fazio, Jean‐Jacques Grob, Natalie Prinzi, Glenn J. Hanna, Jessica C. Hassel, Felix Kiecker, Sara Georges, Barbara Ellers‐Lenz, Parantu K. Shah, Gülseren Güzel, Paul Nghiem - Journal for ImmunoTherapy of Cancer 2021 被引用: 140
A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma
著者: Ciara M. Kelly, Li‐Xuan Qin, Karissa Whiting, Allison L. Richards, Viswatej Avutu, Jason E. Chan, Ping Chi, Mark A. Dickson, Mrinal M. Gounder, Mary Louise Keohan, Sujana Movva, Benjamin A. Nacev, Evan Rosenbaum, Travis E. Adamson, Samuel Singer, Edmund K. Bartlett, Aimeé M. Crago, Sam S. Yoon, Sinchun Hwang, Joseph P. Erinjeri, Cristina R. Antonescu, William D. Tap, Sandra P. D’Angelo - Clinical Cancer Research 2023 被引用: 69
Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib
著者: Mark A. Dickson, Gary K. Schwartz, Mary Louise Keohan, Sandra P. D’Angelo, Mrinal M. Gounder, Ping Chi, Cristina R. Antonescu, Jonathan Landa, Li‐Xuan Qin, Aimeé M. Crago, Samuel Singer, Andrew Koff, William D. Tap - JAMA Oncology 2016 被引用: 324
Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial
著者: Howard L. Kaufman, Jeffery S. Russell, Omid Hamid, Shailender Bhatia, Patrick Terheyden, Sandra P. D’Angelo, Kent C. Shih, Célèste Lebbé, Michèle Milella, Isaac Brownell, Karl D. Lewis, Jochen H. Lorch, Anja von Heydebreck, Meliessa Hennessy, Paul Nghiem - Journal for ImmunoTherapy of Cancer 2018 被引用: 330
Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma
著者: Indu Ramachandran, Daniel E. Lowther, Rebecca Dryer-Minnerly, Ruoxi Wang, Svetlana Fayngerts, Daniel Álvarez Núñez, Gareth Betts, Natalie Bath, Alex J. Tipping, Luca Melchiori, Jean-Marc Navenot, John Glod, Crystal L. Mackall, Sandra P. D’Angelo, Dejka M. Araujo, Warren Chow, George D. Demetri, Mihaela Druta, Brian Andrew Van Tine, Stephan A. Grupp, Albiruni R. Abdul Razak, Breelyn A. Wilky, Malini Iyengar, Trupti Trivedi, Erin Van Winkle, Karen Chagin, Rafael G. Amado, Gwendolyn K. Binder, Samik Basu - Journal for ImmunoTherapy of Cancer 2019 被引用: 145
Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma
著者: Sandra P. D’Angelo, Allison L. Richards, Anthony P. Conley, Hyung Jun Woo, Mark A. Dickson, Mrinal M. Gounder, Ciara M. Kelly, Mary Louise Keohan, Sujana Movva, Katherine A. Thornton, Evan Rosenbaum, Ping Chi, Benjamin A. Nacev, Jason E. Chan, Emily K. Slotkin, Hannah Kiesler, Travis E. Adamson, Lilan Ling, Pavitra Rao, Shreyaskumar Patel, Jonathan A. Livingston, Samuel Singer, Narasimhan P. Agaram, Cristina R. Antonescu, Andrew Koff, Joseph P. Erinjeri, Sinchun Hwang, Li‐Xuan Qin, Mark T.A. Donoghue, William D. Tap - Nature Communications 2022 被引用: 60
Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial
著者: Sandra P. D’Angelo, Shailender Bhatia, Andrew S. Brohl, Omid Hamid, Janice M. Mehnert, Patrick Terheyden, Kent C. Shih, Isaac Brownell, Célèste Lebbé, Karl D. Lewis, Gerald P. Linette, Michèle Milella, Sara Georges, Parantu K. Shah, Barbara Ellers‐Lenz, Marcis Bajars, Gülseren Güzel, Paul Nghiem - Journal for ImmunoTherapy of Cancer 2020 被引用: 197
Long-term clinical activity, safety and patient-reported quality of life for emactuzumab-treated patients with diffuse-type tenosynovial giant-cell tumour
著者: Philippe A. Cassier, Antoîne Italiano, Carlos Gomez‐Roca, Christophe Le Tourneau, Maud Toulmonde, Sandra P. D’Angelo, Kristy Weber, Delphine Loirat, Wolfgang Jacob, Anna-Maria Jegg, Francesca Michielin, R D Christen, Carl Watson, Michael A. Cannarile, Irina Klaman, K. Abiraj, Carola H. Ries, Maja Weisser, Dominik Rüttinger, Jean‐Yves Blay, Jean‐Pierre Delord - European Journal of Cancer 2020 被引用: 68
Recurrent CIC Gene Abnormalities in Angiosarcomas
著者: Shih‐Chiang Huang, Lei Zhang, Yun-Shao Sung, Chun‐Liang Chen, Yu‐Chien Kao, Narasimhan P. Agaram, Samuel Singer, William D. Tap, Sandra P. D’Angelo, Cristina R. Antonescu - The American Journal of Surgical Pathology 2016 被引用: 206